200 related articles for article (PubMed ID: 1462863)
21. Comparative hypertensionology-renal dopaminergic activity in experimental hypertensive rats.
Iimura O; Ura N; Nakagawa M
Clin Exp Hypertens; 1997; 19(1-2):117-30. PubMed ID: 9028640
[TBL] [Abstract][Full Text] [Related]
22. Crucial suppressive role of renal kallikrein-kinin system in development of salt-sensitive hypertension.
Katori M; Majima M; Hayashi I
Biol Res; 1998; 31(3):143-9. PubMed ID: 9830501
[TBL] [Abstract][Full Text] [Related]
23. Role of kinins and prostacyclin in blood pressure regulation.
Bönner G
Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():15-9. PubMed ID: 2514656
[TBL] [Abstract][Full Text] [Related]
24. Response of the renal kallikrein-kinin system, intravascular volume, and renal hemodynamics to sodium restriction and diuretic treatment in essential hypertension.
O'Connor DT
Hypertension; 1982; 4(5 Pt 2):III72-8. PubMed ID: 7049933
[TBL] [Abstract][Full Text] [Related]
25. Renin, kallikrein and prostaglandin renal systems in normotensive boys with and without a family history of essential hypertension.
Rey C; Santos F; Málaga S; Orejas G; Simarro M; Crespo M
J Cardiovasc Risk; 1995 Apr; 2(2):143-8. PubMed ID: 7606651
[TBL] [Abstract][Full Text] [Related]
26. [Renal kallikrein-kinin system. Biochemical and clinical aspects].
Kuska J; Giermakowska-Kowalik T
Postepy Hig Med Dosw; 1984; 38(2):169-85. PubMed ID: 6393102
[No Abstract] [Full Text] [Related]
27. Vascular remodeling and the kallikrein-kinin system.
Carretero OA
J Clin Invest; 2005 Mar; 115(3):588-91. PubMed ID: 15765142
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of antihypertensive effect of atenolol in patients with borderline hypertension during short-term treatment. A comprehensive study.
Imai Y; Abe K; Sato M; Kasai Y; Sato K; Omata K; Sasaki S; Nihei M; Sekino H; Yoshinaga K
Arzneimittelforschung; 1986 May; 36(5):869-73. PubMed ID: 3730023
[TBL] [Abstract][Full Text] [Related]
29. Role of the renal kallikrein-kinin system in the development of salt-sensitive hypertension.
Katori M; Majima M; Hayashi I; Fujita T; Yamanaka M
Biol Chem; 2001 Jan; 382(1):61-4. PubMed ID: 11258674
[TBL] [Abstract][Full Text] [Related]
30. [Role of kallikrein-kinin system and sodium metabolism in the development of hypertension in spontaneously hypertensive rats].
Kohzuki M; Abe K; Yasujima M; Tanno M; Omata K; Kasai Y; Sato M; Kudo K; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1987 Jan; 29(1):57-65. PubMed ID: 3647158
[No Abstract] [Full Text] [Related]
31. Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling.
Madeddu P; Emanueli C; El-Dahr S
Nat Clin Pract Nephrol; 2007 Apr; 3(4):208-21. PubMed ID: 17389890
[TBL] [Abstract][Full Text] [Related]
32. Kallikrein-kinin in stroke, cardiovascular and renal disease.
Chao J; Chao L
Exp Physiol; 2005 May; 90(3):291-8. PubMed ID: 15653716
[TBL] [Abstract][Full Text] [Related]
33. [The kallikrein-kinin system and blood pressure regulation in essential hypertension].
Kohzuki M; Yasujima M
Nihon Rinsho; 1992 Apr; 50 Suppl():318-27. PubMed ID: 1635210
[No Abstract] [Full Text] [Related]
34. [Prostaglandins, kallikrein-kinin and dopamine. Practical implications of this vasodilator-natriuretic system].
Abenhaim L; Kuchel O
Union Med Can; 1979 Jun; 108(6):621-39. PubMed ID: 388782
[No Abstract] [Full Text] [Related]
35. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
[TBL] [Abstract][Full Text] [Related]
36. Study on the renal kallikrein-kinin system in normal and low renin subgroups of essential hypertension.
Iimura O; Shimamoto K; Ura N; Mita T; Tanaka S; Nishimiya T; Nakagawa M; Yamaguchi Y
J Hypertens Suppl; 1984 Dec; 2(3):S297-9. PubMed ID: 6100742
[TBL] [Abstract][Full Text] [Related]
37. The kallikrein/kinin system in ocular function.
Webb JG
J Ocul Pharmacol Ther; 2011 Dec; 27(6):539-43. PubMed ID: 22136090
[TBL] [Abstract][Full Text] [Related]
38. Pivotal role of renal kallikrein-kinin system in the development of hypertension and approaches to new drugs based on this relationship.
Katori M; Majima M
Jpn J Pharmacol; 1996 Feb; 70(2):95-128. PubMed ID: 8866749
[TBL] [Abstract][Full Text] [Related]
39. [Kallikrein-kinin system of the kidneys and blood in hypertension and chronic pyelonephritis].
Panfilov IuA; Baibursian ED
Kardiologiia; 1980 Apr; 20(4):46-8. PubMed ID: 6900131
[TBL] [Abstract][Full Text] [Related]
40. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats.
Ideishi M; Miura S; Sakai T; Sasaguri M; Misumi Y; Arakawa K
J Hypertens; 1994 Jun; 12(6):653-61. PubMed ID: 7963490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
